Comparative effects of β-cyclodextrin, HP-β-cyclodextrin and SBE7-β-cyclodextrin on the solubility and dissolution of docetaxel via inclusion complexation

被引:0
作者
Hadia Sadaquat
Muhammad Akhtar
机构
[1] The Islamia University of Bahawalpur,Department of Pharmacy, Faculty of Pharmacy & Alternative Medicine
来源
Journal of Inclusion Phenomena and Macrocyclic Chemistry | 2020年 / 96卷
关键词
β-cyclodextrin; Hydroxypropyl-β-cyclodextrin; Sulfobutyl ether; -β-cyclodextrin; Docetaxel; Dissolution; Inclusion complex; Solubility;
D O I
暂无
中图分类号
学科分类号
摘要
Cyclodextrins possess the ability to increase the apparent solubility and dissolution rate of poorly water soluble drugs. The objectives of the study were to investigate the effect of β-cyclodextrin, hydroxypropyl-β-cyclodextrin and sulfobutyl ether7 β-cyclodextrin on solubility and dissolution rate of docetaxel. Four different methods (physical mixture, kneading, freeze drying and solvent evaporation) were employed for inclusion complexation, at varying drug to cyclodextrin ratios 1:1, 1:2 and 1:4. The inclusion complexes of docetaxel with β-cyclodextrin, hydroxypropyl-β-cyclodextrin and sulfobutyl ether7 β-cyclodextrin at molar ratios 1:1 were characterized by fourier transform infrared spectroscopy (FTIR), X-ray diffractometry (XRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA) and proton nuclear magnetic resonance (1H NMR). The dissolution profiles of inclusion complexes were compared with pure drug. The results revealed formation of inclusion complexes between drug and β-cyclodextrin, hydroxypropyl-β-cyclodextrin and sulfobutyl ether7 β-cyclodextrin as confirmed by FTIR. 1H NMR revealed inclusion of drug within cyclodextrin cavity with appearance of proton shifts. Drug crystallinity was reduced with physical mixing and kneading method while amorphous form was attained by freeze drying and solvent evaporation method as revealed by XRD. The DSC and TGA confirmed the formation of inclusion complexes with the absence of melting peak of drug. The effect on solubility and dissolution rate of docetaxel was greater with sulfobutyl ether7 β-cyclodextrin than hydroxypropyl-β-cyclodextrin and β-cyclodextrin when prepared with similar methods. Drug to cyclodextrin ratio 1:1 was the optimum ratio to increase the solubility and dissolution of docetaxel irrespective of the method. It is concluded that sulfobutyl ether7 β-cyclodextrin had greater effect on solubility and dissolution rate of docetaxel than β-cyclodextrin and hydroxypropyl-β-cyclodextrin at molar ratios 1:1.
引用
收藏
页码:333 / 351
页数:18
相关论文
共 178 条
[1]  
Ferrati S(2015)Docetaxel/2-hydroxypropyl β-cyclodextrin inclusion complex increases docetaxel solubility and release from a nanochannel drug delivery system Curr. Drug Target. 16 1645-1649
[2]  
Nicolov E(2016)Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile Int. J. Biol. Macromol. 88 206-212
[3]  
Bansal S(2016)A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy J. Biomed. Mater. Res. B 104 789-796
[4]  
Hosali S(2013)How nanotechnology can enhance docetaxel therapy Int. J. Nanomed. 8 2927-108
[5]  
Landis M(2016)Poloxamer-based solid dispersions for oral delivery of docetaxel: differential effects of F68 and P85 on oral docetaxel bioavailability Int. J. Pharm. 507 102-94
[6]  
Grattoni A(2009)Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation J. Control Release. 140 86-84
[7]  
Raza K(2013)Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation Int. J. Nanomed. 8 73-424
[8]  
Kumar N(2009)Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs Curr. Drug Deliv. 6 419-15
[9]  
Misra C(2015)A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs Biomed. Res. Int. 2015 1-210
[10]  
Kaushik L(2011)Preparation and evaluation of silymarin β-cyclodextrin molecular inclusion complexes J. Young Pharm. 3 205-370